Amed Co., Ltd.
Amed Co., Ltd. engages in the research and development, manufacture, and trading of medical equipment in Taiwan. It offers wound care dressing products under the HERADERM brand name; negative pressure wound therapy systems that provides 24-hour oxygen supply to wounds under the Genadyne brand name; and wound treatment systems under the Natrox brand name. The company also provides 7-day long-actin… Read more
Amed Co., Ltd. (7575) - Total Liabilities
Latest total liabilities as of June 2025: NT$786.98 Million TWD
Based on the latest financial reports, Amed Co., Ltd. (7575) has total liabilities worth NT$786.98 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Amed Co., Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Amed Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Amed Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Amed Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Vantage Corp
NYSE MKT:VNTG
|
USA | $8.17 Million |
|
CGPVD
PINK:CGPVD
|
USA | $1.87 Billion |
|
SinglePoint Inc
PINK:SING
|
USA | $18.96 Million |
|
Petrotx - Limited Partnership
TA:PTX
|
Israel | ILA43.99 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Amed Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.68 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Amed Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Amed Co., Ltd. (2019–2024)
The table below shows the annual total liabilities of Amed Co., Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$739.69 Million | +60.87% |
| 2023-12-31 | NT$459.81 Million | -6.58% |
| 2022-12-31 | NT$492.21 Million | +1.85% |
| 2021-12-31 | NT$483.29 Million | +14.22% |
| 2020-12-31 | NT$423.13 Million | +3.86% |
| 2019-12-31 | NT$407.43 Million | -- |